Related Experiment Video
Updated: Jun 5, 2025
07:54
Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
19.7K
Weight Loss for Obstructive Sleep Apnea: Pharmacological and Surgical Management
1Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine, Cheonan Hospital, Cheonan, Republic of Korea.
Journal of Rhinology : Official Journal of the Korean Rhinologic Society
|December 12, 2024
Summary
Obesity significantly contributes to obstructive sleep apnea (OSA). This review examines pharmacological and surgical obesity treatments for adults with OSA, focusing on effective management strategies.
Area of Science:
- Sleep Medicine
- Endocrinology
- Bariatric Medicine
Background:
- Obstructive sleep apnea (OSA) is a prevalent sleep disorder linked to upper airway obstruction.
- Obesity is a major risk factor, causing pharyngeal fat accumulation that narrows airways and worsens OSA.
- OSA complications include excessive daytime sleepiness, hypertension, diabetes, and stroke.
Purpose of the Study:
- To review current pharmacological and surgical management strategies for obesity in adult patients with OSA.
- To provide an overview of treatments for overweight and obese individuals diagnosed with obstructive sleep apnea.
Main Methods:
- Literature review of pharmacological treatments for obesity.
- Literature review of surgical procedures for obesity.
- Analysis of treatment efficacy in overweight and obese adult patients with OSA.
Main Results:
- Pharmacotherapy and bariatric surgery are common interventions for obese patients with OSA.
- Diet, behavioral changes, and exercise show limited success as primary obesity treatments in this population.
- The review synthesizes evidence on the effectiveness of various obesity interventions for OSA management.
Conclusions:
- Pharmacological and surgical interventions are crucial for managing obesity in adults with OSA.
- Effective obesity management is essential for improving OSA symptoms and reducing associated health risks.
- Further research may explore optimized treatment algorithms combining medical and surgical approaches for OSA and obesity.
Related Concept Videos
01:21Sleep Apnea
128
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
128
01:19Management of Insomnia
231
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
231
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:29Gastroesophageal Reflux Disease II: Clinical Features and Management
54
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
54
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
146
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
146
01:26COPD: Management Using Bronchodilators and Corticosteroids
178
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
178